Unknown

Dataset Information

Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.


ABSTRACT: Although clinical outcomes for patients with rheumatoid arthritis (RA) have greatly improved with the use of biologic and conventional DMARDs, approximately 40% of patients do not achieve primary clinical outcomes in randomized trials, and only a small proportion achieve lasting remission. Over the past decade, studies in murine models point to the critical role of the lymphatic system in the pathogenesis and therapy of inflammatory-erosive arthritis, presumably by the removal of catabolic factors, cytokines and inflammatory cells from the inflamed synovium. Murine studies demonstrate that lymphatic drainage increases at the onset of inflammatory-erosive arthritis but, as inflammation progresses to a more chronic phase, lymphatic clearance declines and both structural and cellular changes

SUBMITTER: Bouta EM 

PROVIDER: S-EPMC6475908 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature